NIH-funded research R01 grant

How age-related changes in blood cells may affect gum disease

Official title: Clonal hematopoiesis and periodontal disease

Funded at University of Pennsylvania · NIH-11299496 · Data updated 2026-11-12

Researchers are testing whether age-related mutant blood cells driven by DNMT3A make gum disease worse in older adults.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 1, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$345,313
NIH project number5R01DE033643-03
Project IDNIH-11299496 on NIH RePORTER

Who could benefit from this research

Could help

The research most directly applies to older adults (especially those 65+) with periodontitis and evidence of CHIP, such as DNMT3A mutations.

Less likely to help

Younger people without CHIP or patients whose gum problems are driven mainly by mechanical issues rather than inflammation may be less likely to benefit from these findings.

What this research studies

This project uses mouse models that mimic a common age-related blood change called clonal hematopoiesis (CHIP), focusing on DNMT3A mutations, together with a method that causes gum inflammation to model periodontitis. The team will compare mice with CHIP-like mutations to normal mice to see if mutant white blood cells increase inflammation and bone loss around teeth. They will track whether mutant immune cells move from the bone marrow into the gums and measure inflammatory signals that drive tissue damage. The goal is to reveal mechanisms by which blood-cell changes in older people might worsen periodontal disease and point to possible prevention or treatment targets.

Why it matters

Potential benefit: If successful, this work could explain why older adults with CHIP are more prone to severe gum disease and suggest new ways to prevent or treat it.

How similar studies have gone: Previous studies have linked CHIP to heart disease and shown that mutant blood cells can boost inflammation, but applying this idea to gum disease is a newer, mostly preclinical area.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Hajishengallis, Georgios — University of Pennsylvania
  • Study coordinator: Hajishengallis, Georgios

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.